DNA vaccines induce partial protection against Leishmania mexicana

被引:47
作者
Dumonteil, E
Jesus, RSM
Javier, EO
del Rosario, GMM
机构
[1] Univ Autonoma Yucatan, CIR Dr Hideyo Noguchi, Parasitol Lab, Merida 97000, Yucatan, Venezuela
[2] Univ Autonoma Yucatan, CIR Dr Hideyo Noguchi, Lab Inmunobiol CIR, Merida 97000, Yucatan, Venezuela
关键词
Leishmania mexicana; DNA vaccines; partial protection;
D O I
10.1016/S0264-410X(02)00769-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As part of an ongoing effort to develop a vaccine against Leishmania mexicana, we tested DNA vaccines encoding L mexicana GP63, CPb, and LACK, and L. amazonensis GP46, to evaluate this strategy and define the best antigen candidates. Immune responses and vaccine efficacy were evaluated in BALB/c mice immunized with plasmid DNA encoding the different antigens. All four DNA vaccines induced Leishmania-specific humoral and lympho-proliferative immune responses. However, only mice immunized with VR1012-GP46, VR1012-GP63 and VR1012-CPb were partially protected against infection, as evidenced by reduced lesion size and parasite burden. Interestingly, immunization of mice with a mixture of these three plasmids further increased protection. Thus, plasmids encoding CPb, GP63 and GP46 represent good candidates for further development of DNA vaccines against L. mexicana. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2161 / 2168
页数:8
相关论文
共 42 条
  • [1] Subunit vaccination of mice against new world cutaneous leishmaniasis: Comparison of three proteins expressed in amastigotes and six adjuvants
    Aebischer, T
    Wolfram, M
    Patzer, SI
    Ilg, T
    Wiese, M
    Overath, P
    [J]. INFECTION AND IMMUNITY, 2000, 68 (03) : 1328 - 1336
  • [2] LEISHMANIA-TROPICA AND LEISHMANIA-MEXICANA - CROSS-IMMUNITY IN MICE
    ALEXANDER, J
    PHILLIPS, RS
    [J]. EXPERIMENTAL PARASITOLOGY, 1978, 45 (01) : 93 - 100
  • [3] Alexander J, 1998, J IMMUNOL, V161, P6794
  • [4] Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: Safety, immunogenicity, and efficacy during the first 12 months of follow-up
    Armijos, RX
    Weigel, MM
    Aviles, H
    Maldonado, R
    Racines, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) : 1352 - 1357
  • [5] Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation
    Braun, R
    Babiuk, LA
    Littel-van den Hurk, SV
    [J]. JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 2965 - 2970
  • [6] Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice
    Campos-Neto, A
    Webb, JR
    Greeson, K
    Coler, RN
    Skeiky, YAW
    Reed, SG
    [J]. INFECTION AND IMMUNITY, 2002, 70 (06) : 2828 - 2836
  • [7] de Souza VL, 2000, MICROBES INFECT, V2, P1807, DOI 10.1016/S1286-4579(00)01340-X
  • [8] Dumonteil E, 2000, Dev Biol (Basel), V104, P135
  • [9] DUMONTEIL E, 2002, 4 TDR IDRI M 2 GEN V
  • [10] Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana
    González, CR
    Noriega, FR
    Huerta, S
    Santiago, A
    Vega, M
    Paniagua, J
    Ortiz-Navarrete, V
    Isibasi, A
    Levine, MM
    [J]. VACCINE, 1998, 16 (9-10) : 1043 - 1052